- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
EndoSonics wins clearance for Trak Back
Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics’ intravascular ultrasound (IVUS) imaging catheters, thus
Intravascular ultrasound developer EndoSonics has received Food and Drug Administration clearance for its disposable pull back device, Trak Back. The device allows users to control EndoSonics intravascular ultrasound (IVUS) imaging catheters, thus facilitating both 3-D-like images and cross-sectional displays. Trak Back was designed for use with EndoSonicss Oracle ultrasound systems and Visions Five-64 series of ultrasound catheters.
The device is automated, which the Rancho Cordova, CA, company believes will make it easier to use than competitive IVUS products that are mechanical. Trak Back is part of EndoSonicss strategy to provide its customers with IVUS-guided stenting products by combining its catheters with therapeutic devices. EndoSonics expects to begin shipping Trak Back by the end of the third quarter 1999.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
